UNH Stock Vs. CVS Stock

Core Viewpoint - Health insurance companies, particularly UnitedHealthcare and CVS Health, are facing challenges due to rising medical costs and operational changes, with CVS being viewed as a more attractive investment option despite UnitedHealthcare's stronger revenue growth and profitability metrics [1][11]. Revenue Growth Drivers - CVS has achieved an average annual revenue growth rate of 8.5%, increasing from $292 billion in 2021 to $373 billion in 2024, while UnitedHealth's revenue grew at a rate of 12%, from $285 billion to $400 billion during the same period [2]. - CVS's growth is supported by an increase in total medical membership from 24.4 million in 2021 to 27.1 million currently, driven by the aging U.S. population and strong performance in its pharmacy and consumer wellness business [3]. - UnitedHealth's revenue growth is primarily attributed to its OptumHealth business, which saw a 95% revenue increase from 2021 to 2024, significantly outpacing the overall company growth of 39% [4]. Margin Trends and Cost Pressures - CVS's operating margin declined from 5.2% in 2021 to 2.6% in 2024, while UnitedHealth's operating margin improved from 7.6% to 8.1% during the same timeframe [5]. - CVS's medical benefits ratio rose to 92.5% in 2024 from 85% in 2021, indicating increased pressure on profitability due to rising medical costs, while UnitedHealth's ratio increased from 82.6% to 85.5% [6][7]. Financial Risk Assessment - UnitedHealth has a more favorable financial risk profile with a debt-to-equity ratio of 18% compared to CVS's 107%, and a cash-to-assets ratio of 11% versus CVS's 5% [8]. Stock Performance in Last Four Years - UnitedHealth's stock has decreased by 15% from $330 in early January 2021 to around $280, while CVS's stock has remained stable around $60, both underperforming the S&P 500, which increased by about 55% during the same period [9]. The Verdict – Is CVS A Winner? - Despite UnitedHealth's better revenue growth and profitability, CVS is considered a better investment choice based on its current valuation of 9.4x trailing adjusted earnings compared to UnitedHealth's 9.3x, with CVS undergoing restructuring to improve efficiency and reduce costs [11][12].